INS and Insulin resistance: Chronic suppression of S6K1 activity has been shown to disrupt insulin signaling cascades, culminating in impaired glucose uptake and pancreatic β-cell dysfunction, which predispose to insulin resistance and type 2 diabetes mellitus.